| abstract |
The object of the present invention is to provide a therapeutic agent or a prophylactic agent for inflammatory bowel disease, which has an antagonistic activity against the retinoid-associated orphan γ receptor (RORγ). In order to achieve this object, the present invention relates to a therapeutic agent or a prophylactic agent against inflammatory bowel disease which contains, as active ingredient, a cyclic amine derivative represented by the indicated compound or a pharmacologically acceptable of it. |